Once-a-Day Administration of R(+) Propranolol Is Sufficient to Block Vasculogenesis in a Xenograft Model of Infantile Hemangioma
Objective:. Infantile hemangioma (IH) is a benign vascular tumor that occurs in 5% of infants, predominantly in female and preterm neonates. Propranolol is the mainstay of treatment for IH. Given the short half-life of propranolol regarding β-adrenergic receptor inhibition as well as its side effect...
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Wolters Kluwer Health/LWW
2024-09-01
|
| シリーズ: | Journal of Vascular Anomalies |
| オンライン･アクセス: | http://journals.lww.com/10.1097/JOVA.0000000000000096 |